Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Operating Expenses (2016 - 2017)

Historic Operating Expenses for Bone Biologics (BBLG) over the last 2 years, with Q4 2017 value amounting to $1.3 million.

  • Bone Biologics' Operating Expenses fell 5791.57% to $1.3 million in Q4 2017 from the same period last year, while for Dec 2017 it was $2.6 million, marking a year-over-year decrease of 8713.24%. This contributed to the annual value of $1.1 million for FY2021, which is 3370.39% up from last year.
  • Bone Biologics' Operating Expenses amounted to $1.3 million in Q4 2017, which was down 5791.57% from $1.1 million recorded in Q3 2017.
  • In the past 5 years, Bone Biologics' Operating Expenses ranged from a high of $9.1 million in Q1 2016 and a low of -$2.0 million during Q2 2017